CHRISTINE LAM: Open Payments
NPI 1407498124 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,349 in 116 payments from 19 companies in 2025. Trend: 2023 $4,033 · 2024 $4,047 · 2025 $4,349
Food & beverage: $4,349
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $650 |
| GENZYME CORPORATION | 13 | $592 |
| Incyte Corporation | 14 | $569 |
| Galderma Laboratories, L.P. | 6 | $393 |
| LEO Pharma Inc. | 5 | $333 |
| Regeneron Healthcare Solutions, Inc. | 5 | $326 |
| UCB, Inc. | 4 | $302 |
| Novartis Pharmaceuticals Corporation | 8 | $204 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $180 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $170 |
Products named: DUPIXENT, RINVOQ, OPZELURA, NEMLUVIO, Bimzelx, ADBRY, ILUMYA, OTEZLA.
Industry payments across NY — which companies pay providers there.
